Comparaison du Profil de Résistance dans l'ARN Viral et l'ADN Proviral chez les Adolescents sous Traitement Antirétroviral avec Virémie Détectable au Cameroun - Armando Blondel Djiyou Djeuda, Cameroon

INTEREST 2024

Sexualité Chez Les Adolescents Infectés AU VIH Suivis AU Sein Des Cohortes de Deux Hôpitaux Universitaires AU Sud du Bénin - Lutécia Zohoun, Bénin

INTEREST 2024

Molecular Epidemiology of Human Papillomavirus Circulating in African Countries: Adequacies with HIV-Infection and Oncogenesis, Systematic Review and Meta-Analysis - Larissa Gaelle Moko Fotso, Cameroon

INTEREST 2024

Dynamic Interplay of High-Risk Human Papillomavirus in Women Living with HIV: Persistence, Clearance, Incidence and Synergies with Human T-lymphotropic Virus-1 Infections - James Kangethe, Kenya

INTEREST 2024

New Prevention Technologies - From Research Findings to Access - Linda-Gail Bekker, MBChB, DTMH, DCH, FCP (SA), PhD

INTEREST 2024

Combination Prevention and Contraception - State of the Science - Nyaradzo Mavis Mgodi, MBChB, MMed

INTEREST 2024

Second Speaker Against the Proposition - Ssentongo M. Saadick, MBCHB

INTEREST 2024

Second Speaker For the Proposition - Tiwonge Chimpandule Chirwa, Bsc

INTEREST 2024

First Speaker For the Proposition - Nomathemba Chandiwana, BSc, MBBCh (Wits), MPH, DCH, Hi Dip HIV Man & Sexual Health

INTEREST 2024

Malaria Elimination in Africa: Challenges & Perspectives - Oumar Gaye, MD

INTEREST 2024

Sonographic Patterns of TB – The FASH Scan - Tom Heller, MD

INTEREST 2024

Disseminated HIV-Associated TB and the Treatment - Graeme Meintjes, MBChB, FRCP(Glasg), FCP(SA), MPH, PhD

INTEREST 2024

Transition to 3-Test HIV Testing Algorithm Saves 371 Individuals From Potential Misdiagnosis: Lessons From Malawi’s HIV Testing Program - Tiwonge Chimpandule Chirwa, Malawi

INTEREST 2024

Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs for Combination With the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among (...) - Alex Durand Nka, Cameroon

INTEREST 2024

Eligibility for Long-Acting Cabotegravir/Rilpivirine and Archived Drug Resistance Mutations Among People Living with HIV-1 subtype C in Botswana - Dorcas Maruapula, Botswana

INTEREST 2024

Inability-To-Walk-Unaided - A Single WHO Danger Sign Predicts In- Hospital Mortality in People Living With HIV in a Low-Resource Setting - Chikaiko Malunda, Malawi

INTEREST 2024

HIV-2 - Didier Koumavi Ekouevi, MD, PhD

INTEREST 2024

Interrupting the Unending Cycles of Emerging and Re-Emerging Diseases Outbreaks - A Possibility or Pipe Dream! - Ifedayo Adetifa, MBBS, FWACP (Paediatrics), MSc, PhD

INTEREST 2024

Community Perspective on HIV Progress in Benin - Tiega N Isdine

INTEREST 2024

The Road to 95-95-95: Progress in HIV Prevention and Treatment Scale-up in Sub-Saharan Africa - Berthilde Gahongayire

INTEREST 2024

Current Status of HIV in Benin - Moussa Bachabi, MD, MPH, DES

INTEREST 2024

What Are the Available Tools?

Nurses & Pharmacists HIV Clinical Forum 2023

Positive Approaches to Reduce Stigma

Nurses & Pharmacists HIV Clinical Forum 2023

Boundaries on the Use of Digital Tools/ Ethical and Legal

Nurses & Pharmacists HIV Clinical Forum 2023